{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:45:38Z","timestamp":1791272738919,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QC167"],"award-info":[{"award-number":["ZR2022QC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QC167"],"award-info":[{"award-number":["ZR2022QC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QC167"],"award-info":[{"award-number":["ZR2022QC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QC167"],"award-info":[{"award-number":["ZR2022QC167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85826-1","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:13:16Z","timestamp":1736316796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS)"],"prefix":"10.1038","volume":"15","author":[{"given":"Hui","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"1","key":"85826_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/mp.2009.94","volume":"15","author":"E Young","year":"2010","unstructured":"Young, E. & Korszun, A. Sex, trauma, stress hormones and depression. Mol. Psychiatry. 15 (1), 23\u201328 (2010).","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"85826_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","volume":"62","author":"DS Hasin","year":"2005","unstructured":"Hasin, D. S. et al. Epidemiology of major depressive disorder: results from the national epidemiologic survey on Alcoholism and related conditions. Arch. Gen. Psychiatry. 62 (10), 1097\u20131110 (2005).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"85826_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1054-139X(03)00275-1","volume":"34","author":"RG Wight","year":"2004","unstructured":"Wight, R. G., Sepulveda, J. E. & Aneshensel, C. S. Depressive symptoms: how do adolescents compare with adults? J. Adolesc. Health. 34 (4), 314\u2013323 (2004).","journal-title":"J. Adolesc. Health"},{"key":"85826_CR4","doi-asserted-by":"crossref","unstructured":"Chandra, A. et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat. 23 ;(25):1\u2013160. (2005).","DOI":"10.1037\/e414702008-001"},{"key":"85826_CR5","doi-asserted-by":"crossref","unstructured":"Tayebeh Rakhshani, P. et al. The relationship between spiritual health, quality of life, stress, anxiety and depression in working women. Front. Public. Health 2024 Aug 29:121366230 .","DOI":"10.3389\/fpubh.2024.1366230"},{"issue":"1","key":"85826_CR6","doi-asserted-by":"publisher","first-page":"2217263","DOI":"10.1080\/09513590.2023.2217263","volume":"39","author":"S Xu","year":"2023","unstructured":"Xu, S., Wang, X. & Zhang, Y. Et,al.Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function. Gynecol. Endocrinol. 39 (1), 2217263 (2023).","journal-title":"Gynecol. Endocrinol."},{"issue":"8","key":"85826_CR7","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.3390\/ijms24086992","volume":"24","author":"P Zhang","year":"2023","unstructured":"Zhang, P. & Wang, G. Progesterone resistance in endometriosis: current evidence and putative mechanisms. Int. J. Mol. Sci. 24 (8), 6992 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"85826_CR8","doi-asserted-by":"publisher","first-page":"1139858","DOI":"10.3389\/fendo.2023.1139858","volume":"14","author":"F Shao","year":"2023","unstructured":"Shao, F., Li, Y. & Zhao, Y. Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis. Front. Endocrinol. (Lausanne). 14, 1139858 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"85826_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","volume":"53","author":"CL Shufelt","year":"2009","unstructured":"Shufelt, C. L. & Bairey Merz, C. N. Contraceptive hormone use and cardiovascular disease. J. Am. Coll. Cardiol. 53 (3), 221\u2013231 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"85826_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bpobgyn.2020.05.004","volume":"69","author":"M Jewson","year":"2020","unstructured":"Jewson, M., Purohit, P. & Lumsden, M. A. Progesterone and abnormal uterine bleeding\/menstrual disorders. Best Pract. Res. Clin. Obstet. Gynaecol. 69, 62\u201373 (2020).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"5","key":"85826_CR11","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.5070\/D3245040035","volume":"24","author":"SS Bosanac","year":"2018","unstructured":"Bosanac, S. S. et al. Progestins and acne vulgaris: a review. Dermatol. Online J. 24 (5), 13030 (2018).","journal-title":"Dermatol. Online J."},{"issue":"13","key":"85826_CR12","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1111\/febs.16761","volume":"290","author":"L Xiao","year":"2023","unstructured":"Xiao, L. et al. Autism-like behavior of murine offspring induced by prenatal exposure to progestin is associated with gastrointestinal dysfunction due to claudin-1 suppression. FEBS J. 290 (13), 3369\u20133382 (2023).","journal-title":"FEBS J."},{"key":"85826_CR13","doi-asserted-by":"crossref","unstructured":"Sassarini, D. J. Depress. Midlife Women Maturitas 2016 Dec. ; 94:149\u2013154 .","DOI":"10.1016\/j.maturitas.2016.09.004"},{"issue":"11","key":"85826_CR14","doi-asserted-by":"publisher","first-page":"e2239491","DOI":"10.1001\/jamanetworkopen.2022.39491","volume":"5","author":"MK Wium-Andersen","year":"2022","unstructured":"Wium-Andersen, M. K. et al. Association of hormone therapy with Depression during Menopause in a cohort of Danish women. JAMA Netw. Open. 5 (11), e2239491 (2022).","journal-title":"JAMA Netw. Open."},{"key":"85826_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.contraception.2022.10.006","volume":"117","author":"H Guillard","year":"2023","unstructured":"Guillard, H. et al. Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S. Contraception 117, 7\u201312 (2023).","journal-title":"Contraception"},{"issue":"2","key":"85826_CR16","first-page":"196","volume":"01","author":"\u00c9 Guay","year":"2024","unstructured":"Guay, \u00c9. et al. Rapid Improvement of Post-partum Depression with Subanesthetic Racemic Ketamine.J Clin Psychopharmacol. Mar-Apr 01 (2), 196\u2013198 (2024).","journal-title":"Mar-Apr"},{"key":"85826_CR17","doi-asserted-by":"publisher","first-page":"1169735","DOI":"10.3389\/fimmu.2023.1169735","volume":"14","author":"Y Shu","year":"2023","unstructured":"Shu, Y. et al. Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system. Front. Immunol. 14, 1169735 (2023).","journal-title":"Front. Immunol."},{"issue":"2","key":"85826_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-220583","volume":"89","author":"K Bu","year":"2022","unstructured":"Bu, K. et al. Dysphagia Risk in patients prescribed Rivastigmine: a systematic analysis of FDA adverse event reporting system. J. Alzheimers Dis. 89 (2), 721\u2013731 (2022).","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"85826_CR19","doi-asserted-by":"publisher","first-page":"657e1","DOI":"10.1016\/j.ajog.2024.02.006","volume":"230","author":"K Grindlay","year":"2024","unstructured":"Grindlay, K. et al. Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States. Am. J. Obstet. Gynecol. 230 (6), 657e1\u2013657e17 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"85826_CR20","doi-asserted-by":"crossref","unstructured":"Chumakov, E. M. et al. Anxiety and Depression among Transgender people: findings from a cross-sectional online survey in Russia. LGBT Health 2021 Aug-Sep ;8(6):412\u2013419 .","DOI":"10.1089\/lgbt.2020.0464"},{"key":"85826_CR21","doi-asserted-by":"crossref","unstructured":"Eug\u00e8ne, P. et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 11 (1), 3\u201310 (2002 Jan-Feb).","DOI":"10.1002\/pds.668"},{"key":"85826_CR22","doi-asserted-by":"crossref","unstructured":"Bate, A. et al. A bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clin. Pharmacol. 54 (4), 315\u2013321 (1998).","DOI":"10.1007\/s002280050466"},{"issue":"3","key":"85826_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W Du Mouchel","year":"1999","unstructured":"Du Mouchel, W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting. System[J] Am. Stat. 53 (3), 177\u2013190 (1999).","journal-title":"System[J] Am. Stat."},{"issue":"9","key":"85826_CR24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1111\/bcp.14027","volume":"85","author":"A Claire Langlad","year":"2019","unstructured":"Claire Langlad, A. et al. Adverse events reported for levonorgestrel-releasing IUD Mirena\u00ae in France and impact of media coverage. Br. J. Clin. Pharmacol.85 (9), 2126\u20132133 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"85826_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nop2.121","volume":"5","author":"M Horibe","year":"2018","unstructured":"Horibe, M. et al. Contraceptives as possible risk factors for postpartum depression: a retrospective study of the food and drug administration adverse event reporting system, 2004\u20132015. Nurs. Open. 5 (2), 131\u2013138 (2018).","journal-title":"Nurs. Open."},{"issue":"2","key":"85826_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1783\/147118902101196225","volume":"28","author":"M Cox","year":"2002","unstructured":"Cox, M. & Tripp, J. Sarah Blacksell.Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J. Fam Plann. Reprod. Health Care. 28 (2), 73\u201377 (2002).","journal-title":"J. Fam Plann. Reprod. Health Care"},{"issue":"1","key":"85826_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.contraception.2015.04.006","volume":"92","author":"DL Eisenberg","year":"2015","unstructured":"Eisenberg, D. L. et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception 92 (1), 10\u201316 (2015).","journal-title":"Contraception"},{"key":"85826_CR28","doi-asserted-by":"crossref","unstructured":"Backman, T., Huhtala, S., Blom, T., Luoto, R. & Rauramo I,Koskenvuo, M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG.2000;107(3):335\u2013339. (2000).","DOI":"10.1111\/j.1471-0528.2000.tb13228.x"},{"issue":"2","key":"85826_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1783\/147118902101196225","volume":"28","author":"M Cox","year":"2002","unstructured":"Cox, M., Tripp, J. & Blacksell, S. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network:5-year report. J. Fam Plann. Reprod. Health Care. 28 (2), 73\u201377 (2002).","journal-title":"J. Fam Plann. Reprod. Health Care"},{"issue":"2","key":"85826_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF03004171","volume":"14","author":"M Elovainio","year":"2007","unstructured":"Elovainio, M. et al. Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system. Int. J. Behav. Med. 14 (2), 70\u201375 (2007).","journal-title":"Int. J. Behav. Med."},{"issue":"12","key":"85826_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1080\/09513590802444167","volume":"24","author":"S Daud","year":"2008","unstructured":"Daud, S. & Ewies, A. A. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecol. Endocrinol. 24 (12), 686\u2013690 (2008).","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"85826_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ajog.2014.12.010","volume":"212","author":"KS Hall","year":"2015","unstructured":"Hall, K. S. et al. Contraception and mental health: a commentary on the evidence and principles for practice. Am. J. Obstet. Gynecol. 212 (6), 740\u2013746 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"85826_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1743-6109.2011.02266.x","volume":"9","author":"P Enzlin","year":"2012","unstructured":"Enzlin, P. et al. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. J. Sex. Med. 9 (4), 1065\u20131073 (2012).","journal-title":"J. Sex. Med."},{"issue":"3","key":"85826_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00404-014-3237-1","volume":"290","author":"A Tazegul Pekin","year":"2014","unstructured":"Tazegul Pekin, A. et al. Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study. Arch. Gynecol. Obstet. 290 (3), 507\u2013511 (2014).","journal-title":"Arch. Gynecol. Obstet."},{"key":"85826_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0010-7824(95)00100-O","volume":"51","author":"C Westhoff","year":"1995","unstructured":"Westhoff, C., Wieland, D. & Tiezzi, L. Depression in users of depo-medroxyprogesterone acetate. Contraception 51, 351\u2013354 (1995).","journal-title":"Contraception"},{"key":"85826_CR36","doi-asserted-by":"crossref","unstructured":"Singata-Madliki, M., Hofmeyr, G. J. & Lawrie, T. A. The effect of depot medroxyprogesterone acetate on postnatal depression: a randomized controlled trial. J. Fam Plann. Reprod. Health Care 2016:1\u20136 .","DOI":"10.1136\/jfprhc-2015-101334"},{"key":"85826_CR37","doi-asserted-by":"crossref","unstructured":"Maria Pia Rogines-Velo & Heberle, A. E. Hadine Joffe. Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy.Menopause. ;19(4):471\u2013475. (2012).","DOI":"10.1097\/gme.0b013e3182333847"},{"key":"85826_CR38","doi-asserted-by":"crossref","unstructured":"Aleknaviciute, J. et al. The levonorgestrel-releasing intrauterine device potentiates stress reactivity. Psychoneuroendocrinology 80, 39\u201345 (2017).","DOI":"10.1016\/j.psyneuen.2017.02.025"},{"issue":"6","key":"85826_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/dneu.22847","volume":"81","author":"A Fahrenkopf","year":"2021","unstructured":"Fahrenkopf, A., Li, G. & Wood, R. I. Developmental exposure to the synthetic progestin, 17\u03b1-hydroxyprogesterone caproate, disrupts the mesocortical serotonin pathway and alters impulsive decision-making in rats. Dev. Neurobiol. 81 (6), 763\u2013773 (2021).","journal-title":"Dev. Neurobiol."},{"issue":"6","key":"85826_CR40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.12740\/PP\/OnlineFirst\/151570","volume":"57","author":"AJ Krupa","year":"2023","unstructured":"Krupa, A. J., Wojtasik-Bakalarz, K. & Siwek, M. Vortioxetine-pharmacological properties and use in mood disorders. The current state of knowledge. Psychiatr Pol. 57 (6), 1109\u20131126 (2023).","journal-title":"Psychiatr Pol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85826-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:04:06Z","timestamp":1736359446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85826-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85826-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4639254\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Hui Gao was responsible for the design of the research, experimental data analysis, and manuscript preparation.Xiaohan Zhai and Yan Hu were responsible for the interpretation of data. Hang Wu was responsible for designed and directed the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1302"}}